BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22517003)

  • 21. Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen.
    Johnson ES; Anand RK; Chiu DT
    Anal Chem; 2015 Sep; 87(18):9389-95. PubMed ID: 26302174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The detection of EpCAM(+) and EpCAM(-) circulating tumor cells.
    de Wit S; van Dalum G; Lenferink AT; Tibbe AG; Hiltermann TJ; Groen HJ; van Rijn CJ; Terstappen LW
    Sci Rep; 2015 Jul; 5():12270. PubMed ID: 26184843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies.
    Weissenstein U; Schumann A; Reif M; Link S; Toffol-Schmidt UD; Heusser P
    BMC Cancer; 2012 May; 12():206. PubMed ID: 22646670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EpCAM expression in breast cancer cells is associated with enhanced bone metastasis formation.
    Hiraga T; Ito S; Nakamura H
    Int J Cancer; 2016 Apr; 138(7):1698-708. PubMed ID: 26576938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the specificity and selectivity of anti-EpCAM antibodies in breast cancer cell lines.
    Sterzynska K; Kempisty B; Zawierucha P; Zabel M
    Folia Histochem Cytobiol; 2012; 50(4):534-41. PubMed ID: 23264216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
    Lee JS; Melisko ME; Magbanua MJ; Kablanian AT; Scott JH; Rugo HS; Park JW
    Breast Cancer Res Treat; 2015 Nov; 154(2):339-49. PubMed ID: 26520840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method.
    Bozzetti C; Quaini F; Squadrilli A; Tiseo M; Frati C; Lagrasta C; Azzoni C; Bottarelli L; Galetti M; Alama A; Belletti S; Gatti R; Passaro A; Gradilone A; Cavazzoni A; Alfieri R; Petronini PG; Bonelli M; Falco A; Carubbi C; Pedrazzi G; Nizzoli R; Naldi N; Pinto C; Ardizzoni A
    PLoS One; 2015; 10(11):e0142891. PubMed ID: 26571236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
    Yie SM; Luo B; Ye NY; Xie K; Ye SR
    Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IGFBP1 in epithelial circulating tumor cells as a potential response marker to selective internal radiation therapy in hepatocellular carcinoma.
    Nel I; Baba HA; Weber F; Sitek B; Eisenacher M; Meyer HE; Schlaak JF; Hoffmann AC
    Biomark Med; 2014; 8(5):687-98. PubMed ID: 25123037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent downregulation of the pancarcinoma-associated epithelial cell adhesion molecule via active intranuclear methylation.
    van der Gun BTF; Wasserkort R; Monami A; Jeltsch A; Raskó T; Ślaska-Kiss K; Cortese R; Rots MG; de Leij LFMH; Ruiters MHJ; Kiss A; Weinhold E; McLaughlin PMJ
    Int J Cancer; 2008 Jul; 123(2):484-489. PubMed ID: 18398839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of MUC1 and EpCAM mRNA as tumor markers in differentiating benign from malignant pleural effusion.
    Sun W; Li J; Jiang HG; Ge LP; Wang Y
    QJM; 2014 Dec; 107(12):1001-7. PubMed ID: 24939190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A negative selection system PowerMag for effective leukocyte depletion and enhanced detection of EpCAM positive and negative circulating tumor cells.
    Lin HC; Hsu HC; Hsieh CH; Wang HM; Huang CY; Wu MH; Tseng CP
    Clin Chim Acta; 2013 Apr; 419():77-84. PubMed ID: 23415697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma.
    Sergeant G; Roskams T; van Pelt J; Houtmeyers F; Aerts R; Topal B
    BMC Cancer; 2011 Jan; 11():47. PubMed ID: 21281486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research.
    Grover PK; Cummins AG; Price TJ; Roberts-Thomson IC; Hardingham JE
    Ann Oncol; 2014 Aug; 25(8):1506-16. PubMed ID: 24651410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer.
    Lee CH; Hsieh JC; Wu TM; Yeh TS; Wang HM; Lin YC; Chen JS; Lee CL; Huang WK; Hung TM; Yen TT; Chan SC; Chou WC; Kuan FC; Hu CC; Chang PH
    BMC Cancer; 2019 Dec; 19(1):1167. PubMed ID: 31791269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating tumor cells in early breast cancer: A connection with vascular invasion.
    Maltoni R; Fici P; Amadori D; Gallerani G; Cocchi C; Zoli M; Rocca A; Cecconetto L; Folli S; Scarpi E; Serra P; Fabbri F
    Cancer Lett; 2015 Oct; 367(1):43-8. PubMed ID: 26184997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
    Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.
    Osta WA; Chen Y; Mikhitarian K; Mitas M; Salem M; Hannun YA; Cole DJ; Gillanders WE
    Cancer Res; 2004 Aug; 64(16):5818-24. PubMed ID: 15313925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of front-line chemotherapy on circulating CK-19 mRNA-positive cells in patients with metastatic breast cancer.
    Georgoulias V; Apostolaki S; Bozionelou V; Politaki E; Perraki M; Georgoulia N; Kalbakis K; Kotsakis A; Xyrafas A; Agelaki S; Mavroudis D
    Cancer Chemother Pharmacol; 2014 Dec; 74(6):1217-25. PubMed ID: 25344760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of EpCAM/MUC1 mRNA-positive cells in non-small cell lung cancer patients.
    Zhu WF; Li J; Yu LC; Wu Y; Tang XP; Hu YM; Chen YC
    Tumour Biol; 2014 Feb; 35(2):1211-9. PubMed ID: 24061641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.